As AT-II contributes to renal fibrosis by various mechanisms, of which one is by TGF-β1 gene induction, it can be hypothesised that AT-II would show similar results to TGF-β1 if the AT1 receptor was expressed more in CRFK cells. The gene discussed is AGTR1; the disease is renal fibrosis.